Allay Therapeutics

About:

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

Website: https://www.allaytx.com

Twitter/X: allaytx

Top Investors: Temasek Holdings, New Enterprise Associates, Arboretum Ventures, Vertex Growth Fund, Pavilion Capital

Description:

Allay is pioneering a new category of ultra-sustained pain therapeutics to transform post-surgical pain management and recuperation for patients and physicians. Allay’s proprietary technology platform combines validated non-opioid analgesics and biopolymers to create dissolvable therapeutics to deliver pain relief within a targeted site over weeks—an order of magnitude greater than the longest-lasting pain treatments currently available. The company’s lead investigational product candidate, ATX101, is currently being evaluated in a Phase 2 clinical study in TKA surgeries. Allay unites a dynamic, global team of entrepreneurs, scientists, clinicians and innovators in the San Francisco Bay Area and Singapore.